Interleukin-12 and tumour necrosis factor-α equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus

Scandinavian Journal of Immunology

Volumn 67, Issue 2, 2008, Pages 204-208

  Zorena, K ^a   Mysliwska J ^a   Mysliwiec M ^a   Balcerska, A ^a   Lipowski, P ^a   Raczynska K ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHOOL CHILD;

ADOLESCENT; ALBUMINURIA; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-12; LOGISTIC MODELS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38149075082     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02054.x     Document Type: Article

References (26)

1. Naldini A, Carraro F. Role of inflamatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005 4 : 3 8.
2. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002 2 : 727 39.
3. Sebag J, McMeel JW. Diabetic retinopathy. Pathogenesis and the role of retina-derived growth factor in angiogenesis. Surv Ophthalmol 1986 6 : 377 41.
4. Schram MT, Chaturvedi N, Schalkwijk C et al. EURODIAB Prospective Complications Study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003 26 : 2165 73.
5. McCourt M, Wang JH, Sookhai S, Redmond HP. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 1999 134 : 1325 9.
6. Farilla L, Dotta F, Di Mario U, Rapoport B, McLachlan SM. Presence of interleukin 4 or interleukin 10, but not both cytokines, in pancreatic tissue of two patients with recently diagnosed diabetes mellitus type I. Autoimmunity 2000 32 : 161 8.
7. Naldini A, Aarden L, Pucci A, Bernini C, Carraro F. Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses. Br J Pharmacol 2003 140 : 980 6.
8. Manetti R, Gerosa F, Giudizi MG, Piccinni MP, Maggi E. Interleukin 12 induces sable priming for interferon-γ. Production during differentiation of human T helper cells and transient IFN-γ production in established Th2 cell clones. J Exp Med 1994 179 : 1273 83.
9. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J. Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995 87 : 581 6.
10. Strasly M, Cavallo F, Geuna M et al. IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol 2001 166 : 3890 9.
11. Trinchieri G. Biological properties and therapeutic applications of interleukin-12. Eur Cytokine Netw 1997 8 : 305 7.
12. Colombo MP, Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 2002 13 : 155 68.
13. Gee MS, Procopio WN, Makonnen S, Feldman MD, Yeilding NM, Lee WM. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am J Pathol 2003 162 : 183 93.
14. Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH. Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 2001 42 : 1586 91.
15. Zorena K, Myśliwska J, Myśliwiec M et al. Serum TNF-alpha level predicts nonprolifetative diabetic retinopathy in children. Mediators Inflamm 2007 (in press).
16. Myśliwiec M, Zorena K, Balcerska A, Myśliwska J, Lipowski P, Raczyńska K. The activity of N-acetyl-beta-d- glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Clin Bioch 2006 39 : 851 6.
17. American Diabetes Association. Fallow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 : 3160 7.
18. Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology 1991 98 (Suppl. 5 807 22.
19. Microalbuminuria Collaborative Study Group, UK. Risk Factors or development of microalbuminuria in insulin dependent diabetic patients: Cohort Study. Brit Med J 1993 306 : 1235 9.
20. Rothe H, Burkart V, Faust A, Kolb XX. Interleukin 12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 1996 39 : 112 22.
21. Winkler G, Dworak O, Salamon F, Salamon D, Speer G, Cseh K. Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetologia 1998 41 : 488.
22. Skopiński P, Barcz E, Szaflik J et al. Angiogenic activity and IL-12 p40 concentration in healthy people and diabetes patients sera. Cent Eur J Immun 2006 31 : 1 2.
23. Głowacka E, Banasik M, Lewkowicz P, Tchórzewski H. The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scan J Immunol 2002 2 : 210 7.
24. Angiolillo AL, Sgadari C, Tosato G. A role for the interferon- inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann N Y Acad Sci 1996 31 : 158 67.
25. Sgadari C, Angiolillo AL, Tosato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 1996 87 : 3877 82.
26. Yao L, Sgadari C, Furuke K, Bloom ET, Teruya-Feldstein J, Tosato G. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 1999 93 : 1612 21.